Position in RLAY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,124,430
+$4,740,247 QoQ
Shares Held
541,124
0.0% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#58
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ArrowMark Colorado Holdings LLC holds $294,624,620 across 32 Biotechnology names. RLAY ranks #11 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
4,105,095 | $32,224,995 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
564,069 | $26,533,805 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
767,383 | $22,898,708 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
708,385 | $22,144,115 | |
| 5 | RPRX |
Royalty Pharma plc
|
366,199 | $20,532,777 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
46,030 | $15,410,383 | |
| 7 | ZBIO |
Zenas BioPharma, Inc.
|
573,318 | $14,550,810 | |
| 8 | CGON |
CG Oncology, Inc.
|
155,354 | $11,037,901 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,124,430 | 541,124 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,384,183 | 541,124 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,577,909 | 541,124 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,824,667 | 541,124 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,872,289 | 541,124 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,417,744 | 541,124 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,229,430 | 541,124 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,831,157 | 541,124 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,528,128 | 541,124 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $33,242,911 | 4,005,170 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $43,095,848 | 3,914,246 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,046,969 | 3,810,579 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,938,482 | 3,418,669 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $43,978,144 | 2,670,197 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,139,462 | 2,686,711 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $56,203,909 | 2,512,468 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $47,581,272 | 2,840,673 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $60,611,662 | 2,025,114 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $62,443,380 | 2,033,324 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,959,371 | 442,733 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,618,615 | 372,195 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,734,302 | 339,436 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,141,912 | 340,277 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,691,590 | 344,954 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||